PHILIP H. MOISE - Corporate Board Profile

CoreCard Corp

Filing Date	Source Excerpt
2013-04-04	Philip H. Moise is nominated for election to the Board for a three year term ending at the 2016 Annual Meeting of Shareholders to fill the position held by Dr. John Peatman who is retiring at the end of his term in May 2013. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. Immucor manufactures and sells instruments and reagents used to classify components of human blood prior to blood therapies and transfusions. Previously a publicly-held company, Immucor was acquired and taken private in 2011. Before joining Immucor, Mr. Moïse was in the private practice of law for almost 30 years, where he represented public and private companies in the technology and life sciences industries. He represented Intelligent Systems for approximately 25 years before joining Immucor in 2007. The Board considered Mr. Moise’s familiarity with the company’s business and history; his business experience as an executive with a publicly traded company; his extensive legal background and experience in corporate transactions and corporate governance; and his familiarity with board and regulatory matters impacting publicly traded companies in determining that he should serve as a director of the company. The Board has determined that Mr. Moise qualifies as an independent director under the applicable rules of NYSE MKT.
2014-04-04	Philip H. Moise was elected to the Board in 2013 for a three-year term ending at the 2016 Annual Meeting of Shareholders. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012... The Board has determined that Mr. Moise qualifies as an independent director under the applicable rules of NYSE MKT. The table below sets forth all compensation earned by non-executive directors in the year ended December 31, 2013... Philip H. Moise 6,650 Fees Earned or Paid in Cash, 5,250 Option Awards, Total 11,900.
2015-04-13	Philip H. Moise was elected to the Board in 2013. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. Audit Committee Compensation Committee Director Compensation Philip H. Moise Fees Earned or Paid in Cash: $16,000 Option Awards: $4,240 Total: $20,240
2016-04-01	Philip H. Moise was elected to the Board in 2013 and is being nominated for re-election to the Board for a three year term ending in 2019. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. ... The Board has a Compensation Committee consisting of three independent directors, Messrs. Moise and Petit and Ms. Fuzzell. ... The table below sets forth all compensation earned by non-executive directors in the year ended December 31, 2015. ... Philip H. Moise 16,000 fees earned in cash, 8,400 option awards, total 24,400.
2017-04-05	Philip H. Moise has served as a director since 2013. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. The Audit Committee of the Board met four times during 2016. During 2016, the Audit Committee consisted of Ms. Fuzzell (chair) and Messrs. Petit and Moise. The Board has a Compensation Committee consisting of three independent directors, Messrs. Moise and Petit and Ms. Fuzzell. The table below sets forth all compensation earned by non-executive directors in the year ended December 31, 2016. Philip H. Moise Fees Earned or Paid in Cash $16,000 Option Awards $9,760 Total $25,760.
2018-04-02	Philip H. Moise has served as a director since 2013. The Director Compensation table shows total compensation of $25,340 for 2017. He serves on the Audit Committee and Compensation Committee.
2019-04-12	Philip H. Moise has served as a director since 2013. He is being nominated for re-election to the Board for a three year term ending in 2022. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. ... The Board has a Compensation Committee consisting of three independent directors, Messrs. Chandler, Moise (chair) and Petit. ... The table below sets forth all compensation earned by non-executive directors in the year ended December 31, 2018. ... Philip H. Moise 16,000 (cash) + 19,457 (option awards) = 35,457 total.
2020-07-13	During 2019, the Audit Committee consisted of Mr. Chandler (chair) and Mr. Moise. The Board has a Compensation Committee consisting of two independent directors, Messrs. Chandler and Moise (chair). The table below sets forth all compensation earned by non-executive directors in the year ended December 31, 2019. Philip H. Moise earned $16,000 in fees and $99,240 in option awards, totaling $115,240.
2021-04-09	Philip H. Moise has served as a director since 2013. The Director Compensation table shows his total compensation in 2020 was $100,000. He serves on the Audit Committee and is Chair of the Compensation Committee.
2022-04-08	Philip H. Moise has served as a director since 2013. Mr. Moise served as Executive Vice President, General Counsel and Secretary of Immucor, Inc. from 2007 until 2012. ... The Board has determined that Mr. Moise qualifies as an independent director under the applicable rules of NYSE. ... In 2021, the Audit Committee consisted of Mr. Chandler (chair), Mr. Moise and Ms. Camp. ... The Board has a Compensation Committee consisting of three independent directors, Mr. Chandler, Mr. Moise (chair) and Ms. Camp. ... The Nominating and Corporate Governance Committee consisting of three independent directors, Mr. Chandler, Mr. Moise and Ms. Camp (chair). ... The table below sets forth all compensation earned by non-executive directors in the year ended December 31, 2021. ... Philip H. Moise Fees Earned or Paid in Cash $50,000 Stock Awards $50,000 Total $100,000.
2023-04-14	Philip H. Moise has served as a director since 2013. In 2022, he earned $50,000 in fees and received stock awards valued at $50,000 for a total compensation of $100,000.
2024-04-12	Director, Retired Executive Vice President and General Counsel of Immucor, Inc.